3554343
Last Update Posted: 2021-03-10
Recruiting has ended
All Genders accepted | Under 7 Days |
136339 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Sun May Arise on SMA : Newborn Screening of Spinal Muscular Atrophy in Belgium
Medico-economic study of Newborn screening of Spinal Muscular Atrophy
The aim of this project is to demonstrate the feasibility and the medico-economic impact of a spinal muscular atrophy neonatal screening in a European country. We propose a 3-year-neonatal screening program in Southern Belgium (Wallonia-Brussels Federation) where there is 59.000 newborns/year, among whom 6 are affected by spinal muscular atrophy.
Eligibility
Relevant conditions:
Spinal Muscular Atrophy
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Data sourced from ClinicalTrials.gov